ResMed acquired SAIME, a leading European medical ventilator manufacturer, for €86 million to enhance its portfolio in home ventilation solutions.
Information on the Target
SAIME is an innovative medical company dedicated to improving patient outcomes through advanced respiratory care solutions. They specialize in the design and manufacturing of compact and technically sophisticated medical ventilators that significantly enhance the quality of life for individuals suffering from respiratory conditions.
Under the management of Equistone, SAIME has solidified its position as a frontrunner in the European home ventilation market by expanding its product range and strategically acquiring Take Air Medical, a well-regarded German company specializing in homecare ventilation.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The medical devices industry in Europe, particularly in the respiratory sector, has shown remarkable growth, driven by increasing prevalence of respiratory diseases and a rising aging popu
Similar Deals
NORD Holding → Zentrum Gesundheit
2023
Antin Infrastructure Partners → amedes Holding AG
2023
ResMed
invested in
SAIME
in 2023
in a Late-Stage VC deal
Disclosed details
Transaction Size: $94M